XML 47 R16.htm IDEA: XBRL DOCUMENT v2.4.0.6
Business Segment and Geographic Data
3 Months Ended
Mar. 31, 2013
Business Segment and Geographic Data [Abstract]  
Business Segment and Geographic Data
Note 10
Business Segments and Geographic Data:
 
The Company organized its business into three operating segments to better align its organization based upon the Company's management structure, products and services offered, markets served and types of customers, as follows: The Consumer segment derives its revenues from the design, development, manufacturing and selling of long-term hair reduction and acne consumer products. The Physician Recurring segment derives its revenues from the XTRAC procedures performed by dermatologists, the sales of skincare products, the sales of surgical disposables and accessories to hospitals and surgery centers and on the repair, maintenance and replacement parts on our various products. The Professional segment generates revenues from the sale of equipment, such as lasers, medical and esthetic light and heat-based products and LED products. Management reviews financial information presented on an operating segment basis for the purposes of making certain operating decisions and assessing financial performance.
 
Unallocated operating expenses include costs that are not specific to a particular segment but are general to the group; included are expenses incurred for administrative and accounting staff, general liability and other insurance, professional fees and other similar corporate expenses. Unallocated assets include cash and cash equivalents, prepaid expenses and deposits.
 
The following tables reflect results of operations from our business segments for the periods indicated below:
 
Three Months Ended March 31, 2013
   
CONSUMER
  
PHYSICIAN RECURRING
  
PROFESSIONAL
  
TOTAL
 
Revenues
 $49,060  $5,955  $2,201  $57,216 
Costs of revenues
  7,517   2,931   1,418   11,866 
Gross profit
  41,543   3,024   783   45,350 
Gross profit %
  84.7%  50.8%  35.6%  79.3%
                  
Allocated operating expenses:
                
Engineering and product development
  218   324   231   773 
Selling and marketing expenses
  25,631   3,174   521   29,326 
                  
Unallocated operating expenses
  -   -   -   5,659 
    25,849   3,498   752   35,758 
Income (loss) from operations
  15,694   (474)  31   9,592 
                  
Interest  and other financing income, net
  -   -   -   131 
                  
Net income (loss) before taxes
 $15,694  $( 474) $31  $9,723 
                  

 

Three Months Ended March 31, 2012
   
CONSUMER
  
PHYSICIAN RECURRING
  
PROFESSIONAL
  
TOTAL
 
Revenues
 $42,201  $5,073  $2,999  $50,273 
Costs of revenues
  6,772   2,679   1,783   11,234 
Gross profit
  35,429   2,394   1,216   39,039 
Gross profit %
  84.0%  47.2%  40.5%  77.7%
                  
Allocated operating expenses:
                
Engineering and product development
  237   310   211   758 
Selling and marketing expenses
  22,148   2,530   1,157   25,835 
                  
Unallocated operating expenses
  -   -   -   7,119 
    22,385   2,840   1,368   33,712 
Income (loss) from operations
  13,044   (446)  (152)  5,327 
                  
Interest and other financing expense, net
            -   -   -   (230)
                  
Net income (loss) before taxes
 $13,044  $( 446) $( 152) $5,097 
                  


For the three months ended March 31, 2013 and 2012, net revenues by geographic area were as follows:
 
   
Three Months Ended
March 31,
 
   
2013
  
2012
 
North America 1
 $44,899  $38,689 
Asia Pacific 2
  5,762   5,307 
Europe (including Israel)
  5,633   5,208 
South America
  922   1,069 
   $57,216  $50,273 
          
1 United States
 $38,007  $36,622 
2  Japan
 $4,262  $3,327 
 
As of March 31, 2013 and December 31, 2012, long-lived assets by geographic area were as follows:
 
   
March 31, 2013
  
December 31, 2012
 
   
(unaudited)
    
North America
 $6,641  $5,772 
Asia Pacific
  -   - 
Europe (including Israel)
  1,103   987 
South America
  -   - 
   $7,744  $6,759 
 
The Company discusses segmental details in its Management Discussion and Analysis found elsewhere in this Quarterly Report on Form 10-Q.